Sektor Pelthos Therapeutics Inc.

Aktien

A41BR2

US1711262048

PTHS

Pharmazeutika

Markt geschlossen - 21:00:00 30.10.2026 Perf. 5 T Veränd. 1. Jan.
9.400 USD -43.17% Intraday Chart für Pelthos Therapeutics Inc. -44.71% -69.68%
Hauptkonkurrenten
% % 5 Tage Veränd. 1 Monat Veränd. 3 Monate % 1. Jan. Perf. 1 Jahr Perf. 3 Jahre Veränd. 5 Jahre Veränd. 10 Jahre Marktkap.($)
-43.17%-44.71%-53.81%-67.20%-69.68%-71.52% - - - 35.99 Mio.
+3.19%+11.31%+23.28%+23.39%+31.90%+64.28%+155.66%+468.59%+1’842.37% 1’263 Mrd.
-0.73%+3.56%+5.62%+6.57%+32.01%+44.65%+83.74%+67.59%+136.86% 658 Mrd.
+1.41%+3.24%+13.45%+17.51%+29.06%+35.25%+106.98%+156.85%+422.39% 521 Mrd.
-1.30%+0.33%+15.07%+11.74%+21.21%+53.29%+67.04%+8.26%+77.35% 391 Mrd.
+2.18%+2.93%+3.97%+14.84%+42.05%+73.90%+45.38%+70.22%+152.14% 369 Mrd.
-1.32%+3.47%+13.37%+5.94%+20.35%+32.56%+55.80%+71.66%+89.92% 307 Mrd.
-0.55%+7.86%+16.80%+20.56%+0.54%+12.13%+33.80%+47.07%+206.35% 290 Mrd.
+1.15%+6.09%+14.42%+20.99%+42.38%+56.15%+78.66%+122.13%+231.07% 252 Mrd.
+3.06%+9.38%+15.72%+31.08%+39.06%+42.48%+112.84%+160.02%+130.43% 212 Mrd.
+0.26%+2.48%+7.30%-11.71%-17.94%-15.35%-62.38%-25.24%+124.38% 175 Mrd.
+1.90%+1.63%+8.53%+22.03%+22.57%+23.81%+0.03%-30.06%-1.77% 174 Mrd.
+3.50%+6.67%+10.29%+17.14%+23.28%+31.33%+51.32%+201.45%+617.62% 142 Mrd.
+1.78%+1.63%+1.66%-4.33%+15.83%+35.62%+21.84%+6.48%+22.99% 128 Mrd.
+1.40%-0.62%+10.65%+16.16%+21.25%+22.58%+116.41%+377.98%+669.38% 116 Mrd.
-0.15%+6.76%+12.44%+6.87%-3.75%-8.42%-8.69%-11.15%+10.81% 107 Mrd.
-0.92%-4.15%+3.15%-3.88%+0.60%+4.47%+31.48%-6.15%-8.60% 99.63 Mrd.
+13.33%+15.26%+26.28%+21.67%+20.21%+42.36%+17.27%+45.18%+167.75% 93.11 Mrd.
-0.47%+10.80%+17.35%+304.45%+651.85%+716.35%+190.97%-34.24% - 88.52 Mrd.
-0.58%+4.77%+9.90%+5.62%+22.72%+34.63%+4.88%-28.32%+63.21% 73.45 Mrd.
Durchschnitt -0.80%+2.86%+8.77%+22.97%+47.27%+61.53%+58.05%+87.80%+275.26% 272.9 Mrd.
Nach Marktkapitalisierung gewichteter Durchschnitt +1.33%+6.10%+13.82%+19.78%+35.75%+54.26%+83.30%+166.38%+578.49%
  1. Börse
  2. Aktien
  3. A41BR2 Aktie
  4. Sektor Pelthos Therapeutics Inc.